MED - Medifast, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.24B
Enterprise Value 31.15B
Trailing P/E 17.74
Forward P/E 112.33
PEG Ratio (5 yr expected) 10.77
Price/Sales (ttm)1.94
Price/Book (mrq)9.82
Enterprise Value/Revenue 31.80
Enterprise Value/EBITDA 612.32

Trading Information

Stock Price History

Beta (3Y Monthly) 0.75
52-Week Change 3-55.12%
S&P500 52-Week Change 34.11%
52 Week High 3252.46
52 Week Low 396.40
50-Day Moving Average 3103.63
200-Day Moving Average 3125.84

Share Statistics

Avg Vol (3 month) 3305.3k
Avg Vol (10 day) 3316.53k
Shares Outstanding 511.84M
Float 10.65M
% Held by Insiders 13.98%
% Held by Institutions 197.80%
Shares Short (Aug 15, 2019) 42.48M
Short Ratio (Aug 15, 2019) 46.87
Short % of Float (Aug 15, 2019) 429.44%
Short % of Shares Outstanding (Aug 15, 2019) 420.98%
Shares Short (prior month Jul 15, 2019) 41.67M

Dividends & Splits

Forward Annual Dividend Rate 43
Forward Annual Dividend Yield 42.86%
Trailing Annual Dividend Rate 32.73
Trailing Annual Dividend Yield 32.57%
5 Year Average Dividend Yield 4N/A
Payout Ratio 446.27%
Dividend Date 3Aug 7, 2019
Ex-Dividend Date 4Jun 27, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 11.22%
Operating Margin (ttm)14.00%

Management Effectiveness

Return on Assets (ttm)30.27%
Return on Equity (ttm)62.53%

Income Statement

Revenue (ttm)638.06M
Revenue Per Share (ttm)53.77
Quarterly Revenue Growth (yoy)59.50%
Gross Profit (ttm)379.9M
EBITDA 93.24M
Net Income Avi to Common (ttm)71.57M
Diluted EPS (ttm)5.91
Quarterly Earnings Growth (yoy)51.30%

Balance Sheet

Total Cash (mrq)113.52M
Total Cash Per Share (mrq)9.63
Total Debt (mrq)12.98M
Total Debt/Equity (mrq)10.30
Current Ratio (mrq)2.26
Book Value Per Share (mrq)10.67

Cash Flow Statement

Operating Cash Flow (ttm)69.5M
Levered Free Cash Flow (ttm)47.1M